Subscribe to our Newsletters !!


    AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes

    AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to

    Remedial got from turmeric shows guarantee in treating canine visual condition

    Researchers in Texas A&M University have produced a curative derived from turmeric, a spice long-praised because of its natural anti-inflammatory properties, that shows promise in decreasing ocular inflammation in dogs suffering from uveitis, an inflammation of the eye that leads to pain and reduced vision. Uveitis — a frequent condition in dogs, humans, and other

    Designers develop plant-based splash that could be utilized in N95 mask filters

    Engineers have invented a way to spray extremely thin wires made of a plant-based material that might be used in N95 mask filters, devices that harvest energy for electricity, and potentially the production of human organs. The procedure involves spraying methylcellulose, a renewable plastic material derived from plant cellulose, on 3D-printed and other objects ranging

    New gold-nanoparticle probes for target recognizable proof of bioactive small molecules

    The development of pharmaceutical treatments is difficult — clinicians and researchers know a certain drug can regulate particular functions, but they may not understand how it actually works. Bioactive small molecules are chemical compounds, such as pharmaceuticals, that can be readily delivered to and interact with a human body’s cells. By binding to specific proteins,

    Researchers develop experimental direct-acting antiviral treatment to treat COVID-19

    An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19. Conventional antivirals reduce symptoms and help people recover earlier. Examples